Waldenström macroglobulinemia

A review of therapy

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

Waldenström macroglobulinemia is a rare monoclonal gammopathy-associated lymphoplasmacytic lymphoma. Its incidence is only 4 per million per year. This review contains the known published literature specifically on the available management tools for Waldenström macroglobulinemia and is designed to assist clinicians in making management decisions for patients with this uncommon disorder.

Original languageEnglish (US)
Pages (from-to)147-157
Number of pages11
JournalAmerican Journal of Hematology
Volume79
Issue number2
DOIs
StatePublished - Jun 1 2005

Fingerprint

Waldenstrom Macroglobulinemia
Paraproteinemias
Lymphoma
Decision Making
Incidence
Therapeutics

Keywords

  • Hyperviscosity syndrome
  • Lymphoplasmacytic lymphoma
  • Monoclonal antibody therapy
  • Monoclonal gammopathy
  • Waldenström macroglobulinemia

ASJC Scopus subject areas

  • Hematology

Cite this

Waldenström macroglobulinemia : A review of therapy. / Gertz, Morie.

In: American Journal of Hematology, Vol. 79, No. 2, 01.06.2005, p. 147-157.

Research output: Contribution to journalReview article

@article{33c08c488350495eae251da83a13d393,
title = "Waldenstr{\"o}m macroglobulinemia: A review of therapy",
abstract = "Waldenstr{\"o}m macroglobulinemia is a rare monoclonal gammopathy-associated lymphoplasmacytic lymphoma. Its incidence is only 4 per million per year. This review contains the known published literature specifically on the available management tools for Waldenstr{\"o}m macroglobulinemia and is designed to assist clinicians in making management decisions for patients with this uncommon disorder.",
keywords = "Hyperviscosity syndrome, Lymphoplasmacytic lymphoma, Monoclonal antibody therapy, Monoclonal gammopathy, Waldenstr{\"o}m macroglobulinemia",
author = "Morie Gertz",
year = "2005",
month = "6",
day = "1",
doi = "10.1002/ajh.20363",
language = "English (US)",
volume = "79",
pages = "147--157",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Waldenström macroglobulinemia

T2 - A review of therapy

AU - Gertz, Morie

PY - 2005/6/1

Y1 - 2005/6/1

N2 - Waldenström macroglobulinemia is a rare monoclonal gammopathy-associated lymphoplasmacytic lymphoma. Its incidence is only 4 per million per year. This review contains the known published literature specifically on the available management tools for Waldenström macroglobulinemia and is designed to assist clinicians in making management decisions for patients with this uncommon disorder.

AB - Waldenström macroglobulinemia is a rare monoclonal gammopathy-associated lymphoplasmacytic lymphoma. Its incidence is only 4 per million per year. This review contains the known published literature specifically on the available management tools for Waldenström macroglobulinemia and is designed to assist clinicians in making management decisions for patients with this uncommon disorder.

KW - Hyperviscosity syndrome

KW - Lymphoplasmacytic lymphoma

KW - Monoclonal antibody therapy

KW - Monoclonal gammopathy

KW - Waldenström macroglobulinemia

UR - http://www.scopus.com/inward/record.url?scp=20044392019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044392019&partnerID=8YFLogxK

U2 - 10.1002/ajh.20363

DO - 10.1002/ajh.20363

M3 - Review article

VL - 79

SP - 147

EP - 157

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 2

ER -